Zomedica Announces "Third Friday at Four" Webinar on November 20, 2026: The People Behind Zomedica - Seven Guiding Principles in Action, and Q3 Financial Results
Key Highlights
- ➤Revenue grew 31% through the first three quarters of 2026
- ➤Approximately $41 million in liquidity as of September 30, 2026
- ➤Zomedica will review Q3 2026 financial results November 20
- ➤Zomedica employs approximately 150 people across Georgia and Minnesota facilities
Expert Statements
Larry Heaton, Chief Executive Officer of Zomedica
“Our people themselves are a competitive advantage. The knowledge on this team in diagnostics, therapeutics, manufacturing, and the field, comes from two places: years of building our business here at Zomedica, and careers at many of the largest companies in human and animal health before joining us. We pair that depth with new talent and fresh perspective, and that combination is how we develop, build, and sell products veterinarians trust. This webinar is an opportunity for investors to meet the people behind our results and then hear those results directly from our finance team.”
ANN ARBOR, MI / ACCESS Newswire / November 10, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced the next installment of its "Fourth Friday at Four" investor webinar series. Due to the Thanksgiving holiday, the November session will take place on the third Friday of the month, Friday, November 20, 2026, at 4:00 p.m. Eastern Time.
The November program, titled "The People Behind Zomedica's Competitive Edge and Q3 Financial Results," will give current and prospective investors a look at the people who develop, manufacture, market, and sell Zomedica's products, and why their experience is an advantage competitors cannot easily replicate. The session is organized around the Company's seven guiding principles: Reliance on Each Other, Customer Obsession, Financial Discipline, Innovative R&D, Quality Manufacturing, Creative Marketing, and Tenacious Selling.
Get started
Create a free account to read the full story.